Advertisement

Uncategorized

In June, Houston-based University of Texas MD Anderson Cancer Center earned its sixth Magnet designation and its first Magnet with Distinction rating from the American Nurses Credentialing Center. The latest designation means MD Anderson is one of 26 organizations worldwide…

New Hyde Park, N.Y.-based Northwell Health has appointed Geraldine O’Sullivan Coyne, MD, PhD, to system head and principal investigator for the system’s newly established Start Center for Cancer Research.  The unit — set to be the first Start center in…

Researchers from New York City-based organizations Columbia University and NewYork-Presbyterian have developed an AI tool capable of identifying patients at risk of having undiagnosed structural heart disease.  The tool, called EchoNext, was trained on more than 1.2 million electrocardiogram and…

Seattle-based Fred Hutch Cancer Center will rename an outpatient care facility the Sloan Clinic after donors Stuart and Molly Sloan. The Sloans have increased their giving total to $100 million from $78 million in 2022, according to a July 22…

Advertisement

San Francisco-based UCSF Helen Diller Family Comprehensive Cancer Center and Stanford (Calif.) Cancer Institute have established a new research collaborative, the Weill Cancer Hub West. United by a $100 million matching grant from the Weill Family Foundation, UCSF and Stanford…

Fort Lauderdale-based Holy Cross Health, part of Livonia, Mich.-based Trinity Health, is set to receive a $5 million gift to strengthen heart and vascular care. The planned gift is among the largest Holy Cross Health has received in its 70-year…

COVID-19 cases are rising in at least 26 states, according to the latest CDC data, published July 18.  Four notes: 1. Overall, the level of acute respiratory illness causing people to seek healthcare services across the country is low. However,…

Of all early-onset cancers in the U.S., gastrointestinal cancers are increasing most rapidly, according to a review published July 17 in JAMA.  Defined as occurring in patients under the age of 50, early-onset gastrointestinal cancers include colorectal, gastric, esophageal and…

Combining duvelisib and romidepsin may provide a path to stem cell transplant for patients with relapsed or refractory peripheral and cutaneous T-cell lymphomas.  Researchers from Somerville, Mass.-based Mass General Brigham found the drug combination to be effective, tolerable and safe,…

Advertisement